1. Home
  2. TEVA vs ULTA Comparison

TEVA vs ULTA Comparison

Compare TEVA & ULTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • ULTA
  • Stock Information
  • Founded
  • TEVA 1901
  • ULTA 1990
  • Country
  • TEVA Israel
  • ULTA United States
  • Employees
  • TEVA N/A
  • ULTA N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • ULTA Other Specialty Stores
  • Sector
  • TEVA Health Care
  • ULTA Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • ULTA Nasdaq
  • Market Cap
  • TEVA 19.2B
  • ULTA 16.1B
  • IPO Year
  • TEVA N/A
  • ULTA 2007
  • Fundamental
  • Price
  • TEVA $16.92
  • ULTA $333.93
  • Analyst Decision
  • TEVA Strong Buy
  • ULTA Buy
  • Analyst Count
  • TEVA 8
  • ULTA 25
  • Target Price
  • TEVA $19.63
  • ULTA $425.56
  • AVG Volume (30 Days)
  • TEVA 7.4M
  • ULTA 839.0K
  • Earning Date
  • TEVA 11-06-2024
  • ULTA 12-05-2024
  • Dividend Yield
  • TEVA N/A
  • ULTA N/A
  • EPS Growth
  • TEVA N/A
  • ULTA 0.11
  • EPS
  • TEVA N/A
  • ULTA 24.93
  • Revenue
  • TEVA $16,772,000,000.00
  • ULTA $11,321,166,000.00
  • Revenue This Year
  • TEVA $4.70
  • ULTA $1.61
  • Revenue Next Year
  • TEVA $4.47
  • ULTA $3.76
  • P/E Ratio
  • TEVA N/A
  • ULTA $13.76
  • Revenue Growth
  • TEVA 9.81
  • ULTA 5.51
  • 52 Week Low
  • TEVA $9.35
  • ULTA $318.17
  • 52 Week High
  • TEVA $19.31
  • ULTA $574.76
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.51
  • ULTA 28.47
  • Support Level
  • TEVA $16.15
  • ULTA $378.98
  • Resistance Level
  • TEVA $17.16
  • ULTA $385.93
  • Average True Range (ATR)
  • TEVA 0.49
  • ULTA 9.17
  • MACD
  • TEVA -0.07
  • ULTA -5.08
  • Stochastic Oscillator
  • TEVA 30.38
  • ULTA 4.67

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About ULTA Ulta Beauty Inc.

With 1,385 stores at the end of fiscal 2023 and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the US. The firm offers makeup (41% of 2023 sales), fragrances, skin care (19% of sales), and hair care products (19% of sales), and bath and body items. Ulta offers private-label products and more than 600 individual brands. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.

Share on Social Networks: